Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Medtronic plc Revenue & Financial Statements
Medtronic plc reported revenue of $33.5B for the fiscal year ended April 25, 2025, up 3.6% year over year, with net income of $4.7B and diluted EPS of $3.61.
- Company
- Medtronic plc MDT · NYSE
- Latest fiscal year
- FY ended Apr 25, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 30.1B | 31.7B | 31.2B | 32.4B | 33.5B |
| Cost of revenue | 10.5B | 10.1B | 10.7B | 11.2B | 11.6B |
| Gross profit | 19.6B | 21.5B | 20.5B | 21.1B | 21.9B |
| Operating income | 4.5B | 5.8B | 5.5B | 5.1B | 6.0B |
| Pretax income | (358.0M) | 436.0M | 1.3B | 750.0M | 1.0B |
| Net income | 3.6B | 5.0B | 3.8B | 3.7B | 4.7B |
| Diluted EPS | 2.66 | 3.73 | 2.82 | 2.76 | 3.61 |
| EBITDA | 5.4B | 6.7B | 6.5B | 6.1B | 7.0B |
Quarterly
| USD | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.6B | 7.9B | 8.4B | 8.3B | 8.9B | 8.6B | 9.0B | 85.0M |
| Cost of revenue | 3.0B | 2.8B | 2.9B | 2.8B | 3.1B | 3.0B | 3.1B | 3.3B |
| Gross profit | 5.5B | 5.2B | 5.5B | 5.5B | 5.8B | 5.6B | 5.9B | (3.2B) |
| Operating income | 1.1B | 1.3B | 1.6B | 1.6B | 1.4B | 1.4B | 1.7B | 1.5B |
| Pretax income | 855.0M | 1.3B | 1.6B | 1.5B | 1.3B | 1.3B | 1.6B | 1.4B |
| Net income | 654.0M | 1.0B | 1.3B | 1.3B | 1.1B | 1.0B | 1.4B | 1.1B |
| Diluted EPS | 0.49 | 0.80 | 0.99 | 1.01 | 0.82 | 0.81 | 1.07 | 0.89 |
| EBITDA | 1.7B | 1.9B | — | 2.3B | 2.3B | 1.7B | 2.0B | 2.2B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 93.1B | 91.0B | 90.9B | 90.0B | 91.7B |
| Current assets | 22.5B | 23.1B | 21.7B | 21.9B | 23.8B |
| Cash & equivalents | 3.6B | 3.7B | 1.5B | 1.3B | 2.2B |
| Total liabilities | 41.5B | 38.3B | 39.3B | 39.6B | 43.4B |
| Current liabilities | 8.5B | 12.4B | 9.1B | 10.8B | 12.9B |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | 51.4B | 52.6B | 51.5B | 50.2B | 48.0B |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 6.2B | 7.3B | 6.0B | 6.8B | 7.0B |
| Investing cash flow | (2.9B) | (1.7B) | (3.5B) | (2.4B) | (1.9B) |
| Financing cash flow | (4.1B) | (5.3B) | (5.0B) | (4.5B) | (4.4B) |
| Capital expenditure | 1.4B | 1.4B | 1.5B | 1.6B | 1.9B |
| Free cash flow | 4.9B | 6.0B | 4.6B | 5.2B | 5.2B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 344.0M | 359.0M | 355.0M | 393.0M | 429.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every MDT filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.